...
首页> 外文期刊>Hypertension research: Official journal of the Japanese Society of Hypertension >Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease
【24h】

Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease

机译:肠道微生物肿瘤和慢性肾病的炎症及其在心血管疾病发展中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The health and proper functioning of the cardiovascular and renal systems largely depend on crosstalk in the gut-kidney-heart/vessel triangle. Recent evidence suggests that the gut microbiota has an integral function in this crosstalk. Mounting evidence indicates that the development of chronic kidney and cardiovascular diseases follows chronic inflammatory processes that are affected by the gut microbiota via various immune, metabolic, endocrine, and neurologic pathways. Additionally, deterioration of the function of the cardiovascular and renal systems has been reported to disrupt the original gut microbiota composition, further contributing to the advancement of chronic cardiovascular and renal diseases. Considering the interaction between the gut microbiota and the renal and cardiovascular systems, we can infer that interventions for the gut microbiota through diet and possibly some medications can prevent/stop the vicious cycle between the gut microbiota and the cardiovascular/renal systems, leading to a decrease in chronic cardiovascular and renal diseases.
机译:心血管和肾体系的健康和正常运作在很大程度上取决于肠肾心脏/血管三角形的串扰。最近的证据表明,肠道微生物群在这种串扰中具有整体功能。安装证据表明,慢性肾和心血管疾病的发展遵循慢性炎症过程,其通过各种免疫,代谢,内分泌和神经途径受到肠道微生物群的影响。另外,据报道,心血管和肾体系的劣化扰乱了原始的肠道微生物群组合物,进一步促进了慢性心血管和肾病的推进。考虑到肠道微生物群和肾和心血管系统之间的相互作用,我们可以推断通过饮食和可能一些药物的肠道微生物群的干预措施可以预防/停止肠道微生物群和心血管/肾脏系统之间的恶性循环,导致a减少慢性心血管和肾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号